← Blog | Research January 2026

BPC-157 vs TB-500: What’s the Difference?

Category: Research Guides • Reading time: ~6 minutes

BPC-157 and TB-500 are two of the most studied recovery-related research peptides available today. Both have been investigated for their roles in tissue repair and healing processes, but they work through entirely different mechanisms and act on different biological targets. Understanding those differences is essential for designing meaningful research.

This guide compares the two compounds directly — their origins, mechanisms, research areas, and practical handling considerations.

Both BPC-157 and TB-500 are sold for research purposes only and are not intended for human use.

Origins and Background

BPC-157

BPC-157 (Body Protection Compound 157) is a 15-amino-acid synthetic peptide derived from a protein found in human gastric juice. It was first isolated in the 1990s by researchers studying the cytoprotective properties of the gastric mucosa. Its stability in acidic environments and broad range of preclinical effects have made it a widely used research tool.

Read the full overview: What is BPC-157?.

TB-500

TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), a naturally occurring protein found in virtually all human and animal cells. Tβ4 plays a fundamental role in actin polymerisation — the process by which cells build their internal structural skeleton and move through tissue. TB-500 corresponds to the actin-binding domain of Thymosin Beta-4 (specifically the amino acid sequence LKKTETQ) and is studied because it appears to retain many of the biological activities of the full-length protein in preclinical models.

Mechanisms of Action: Where They Differ

Property

BPC-157

TB-500

Origin

Derived from gastric protein BPC

Fragment of Thymosin Beta-4 (Tβ4)

Length

15 amino acids

7 amino acids (LKKTETQ)

Primary Mechanism

Angiogenesis, growth factor modulation, NO pathway, FAK/Src signalling

Actin sequestration, cell migration, anti-inflammatory

Vascular Effects

Strong — stimulates VEGF/angiogenesis

Moderate — supports vessel formation indirectly

Cell Migration

Moderate

Strong — primary mechanism

Key Tissue Focus

Gut, tendon, bone, systemic

Muscle, skin, heart, eye, systemic

Stability

High — stable in acidic environments

Moderate — standard peptide stability

Research Volume

Very high — extensive preclinical data

High — strong research base

Research Areas: Where Each Compound Has Been Studied

BPC-157 Preclinical Research Focus

TB-500 Preclinical Research Focus

Which to Choose for Your Research?

The right compound depends on the biological question you’re investigating:

Browse products: BPC-157 | TB-500 | BPC-157 + TB-500 Blend.

⚠️ Research Use Disclaimer

All peptides sold by Peptide Research Store are intended strictly for in vitro research and laboratory use only. They are not intended for human or veterinary use, consumption, or therapeutic application of any kind. These products have not been evaluated by Health Canada or the FDA for safety or efficacy in humans. By purchasing, you confirm you are a qualified researcher using products in accordance with all applicable laws.

Reviewed by the Peptide Research Store editorial team • Last updated: March 2026 • Sources: PubMed / NCBI